
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hippocampal Pathology in Clinical High-Risk Patients and the Onset of Schizophrenia
Frank A. Provenzano, Jia Guo, Melanie M. Wall, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 3, pp. 234-242
Closed Access | Times Cited: 82
Frank A. Provenzano, Jia Guo, Melanie M. Wall, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 3, pp. 234-242
Closed Access | Times Cited: 82
Showing 1-25 of 82 citing articles:
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 189
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 189
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 59
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 59
Mapping Lesions That Cause Psychosis to a Human Brain Circuit and Proposed Stimulation Target
Andrew R. Pines, Summer Frandsen, William Drew, et al.
JAMA Psychiatry (2025)
Closed Access | Times Cited: 2
Andrew R. Pines, Summer Frandsen, William Drew, et al.
JAMA Psychiatry (2025)
Closed Access | Times Cited: 2
Relations of temporoparietal connectivity with neighborhood social fragmentation in youth at clinical high-risk for psychosis
Katrina Aberizk, Esra Sefik, Qingyue Yuan, et al.
Schizophrenia Research (2025) Vol. 277, pp. 151-158
Closed Access | Times Cited: 2
Katrina Aberizk, Esra Sefik, Qingyue Yuan, et al.
Schizophrenia Research (2025) Vol. 277, pp. 151-158
Closed Access | Times Cited: 2
Potential Roles of Redox Dysregulation in the Development of Schizophrenia
Diana O. Perkins, Clark Jeffries, Kim Q.
Biological Psychiatry (2020) Vol. 88, Iss. 4, pp. 326-336
Open Access | Times Cited: 85
Diana O. Perkins, Clark Jeffries, Kim Q.
Biological Psychiatry (2020) Vol. 88, Iss. 4, pp. 326-336
Open Access | Times Cited: 85
Philipp G. Sämann, Juan Eugenio Iglesias, Boris A. Gutman, et al.
Human Brain Mapping (2020) Vol. 43, Iss. 1, pp. 207-233
Open Access | Times Cited: 85
Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models
David Wegrzyn, Georg Juckel, Andréas Faissner
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5482-5482
Open Access | Times Cited: 41
David Wegrzyn, Georg Juckel, Andréas Faissner
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5482-5482
Open Access | Times Cited: 41
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation
Gilly Wolf, Sandeep Singh, Karin Blakolmer, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 44-58
Closed Access | Times Cited: 38
Gilly Wolf, Sandeep Singh, Karin Blakolmer, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 44-58
Closed Access | Times Cited: 38
The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
Daniela L. Uliana, João Roberto Lisboa, Felipe V. Gomes, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116298-116298
Closed Access | Times Cited: 13
Daniela L. Uliana, João Roberto Lisboa, Felipe V. Gomes, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116298-116298
Closed Access | Times Cited: 13
Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model
Guangdan Yu, Yixun Su, Guo Chen, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 12, pp. 5154-5166
Open Access | Times Cited: 33
Guangdan Yu, Yixun Su, Guo Chen, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 12, pp. 5154-5166
Open Access | Times Cited: 33
Detecting schizophrenia with 3D structural brain MRI using deep learning
Junhao Zhang, Vishwanatha M. Rao, Ye Tian, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Junhao Zhang, Vishwanatha M. Rao, Ye Tian, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Hippocampal volume in early psychosis: a 2-year longitudinal study
Maureen McHugo, Kristan Armstrong, Maxwell J. Roeske, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Maureen McHugo, Kristan Armstrong, Maxwell J. Roeske, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Hippocampal circuit dysfunction in psychosis
Samuel Knight, Robert A. McCutcheon, Daniella Dwir, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Samuel Knight, Robert A. McCutcheon, Daniella Dwir, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
Helen Baldwin, Joaquim Radúa, Mathilde Antoniades, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Helen Baldwin, Joaquim Radúa, Mathilde Antoniades, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms
Valentina Mancini, Muhammad G. Saleh, Farnaz Delavari, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 7, pp. 569-579
Open Access | Times Cited: 15
Valentina Mancini, Muhammad G. Saleh, Farnaz Delavari, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 7, pp. 569-579
Open Access | Times Cited: 15
Smaller anterior hippocampal subfields in the early stage of psychosis
Maureen McHugo, Maxwell J. Roeske, Simon Vandekar, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Maureen McHugo, Maxwell J. Roeske, Simon Vandekar, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Early life stress and functional connectivity in antipsychotic-naïve first episode psychosis patients
Hillary N. Patton, Jose O. Maximo, James Bryant, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Hillary N. Patton, Jose O. Maximo, James Bryant, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Comprehensive bioinformatics analysis identifies hub genes associated with immune cell infiltration in early-onset schizophrenia
Shasha Wu, Tailian Xue, Yilin Li, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Shasha Wu, Tailian Xue, Yilin Li, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis
F. Dybowski, Daniel S. Scott, Carol A. Tamminga
Neuropsychopharmacology (2025)
Closed Access
F. Dybowski, Daniel S. Scott, Carol A. Tamminga
Neuropsychopharmacology (2025)
Closed Access
Discovery of biological markers for schizophrenia based on metabolomics: a systematic review
Gaolei Yao, Jingchun Zeng, Yuan Huang, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Gaolei Yao, Jingchun Zeng, Yuan Huang, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats
Xiyu Zhu, Anthony A. Grace
Biological Psychiatry (2020) Vol. 89, Iss. 3, pp. 298-307
Open Access | Times Cited: 35
Xiyu Zhu, Anthony A. Grace
Biological Psychiatry (2020) Vol. 89, Iss. 3, pp. 298-307
Open Access | Times Cited: 35
Meta-analysis and open-source database for in vivo brain Magnetic Resonance spectroscopy in health and disease
Aaron T. Gudmundson, Annie Koo, Anna Virovka, et al.
Analytical Biochemistry (2023) Vol. 676, pp. 115227-115227
Open Access | Times Cited: 12
Aaron T. Gudmundson, Annie Koo, Anna Virovka, et al.
Analytical Biochemistry (2023) Vol. 676, pp. 115227-115227
Open Access | Times Cited: 12
Dopamine and glutamate in individuals at high risk for psychosis: a meta‐analysis of in vivo imaging findings and their variability compared to controls
Robert A. McCutcheon, Kate Merritt, Oliver Howes
World Psychiatry (2021) Vol. 20, Iss. 3, pp. 405-416
Open Access | Times Cited: 26
Robert A. McCutcheon, Kate Merritt, Oliver Howes
World Psychiatry (2021) Vol. 20, Iss. 3, pp. 405-416
Open Access | Times Cited: 26
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner
Sung Min Yang, Ayan Ghoshal, Jeffrey M. Hubbard, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 7, pp. 1091-1103
Open Access | Times Cited: 9
Sung Min Yang, Ayan Ghoshal, Jeffrey M. Hubbard, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 7, pp. 1091-1103
Open Access | Times Cited: 9